Literature DB >> 26928565

Factors associated with anxiety and depressive symptoms in colorectal cancer survivors.

Annemarie M J Braamse1, Sietze T van Turenhout, Jochim S Terhaar Sive Droste, Gerrit H de Groot, René W M van der Hulst, Michael Klemt-Kropp, Sjoerd D Kuiken, Ruud J L F Loffeld, M Tessa Uiterwaal, Chris J J Mulder, Joost Dekker.   

Abstract

BACKGROUND: Up to 37% of colorectal cancer (CRC) survivors report depressive and anxiety symptoms. The identification of risk factors for depressive or anxiety symptoms might help focus supportive care resources on those patients most in need. The present study aims to explore which factors are associated with heightened anxiety or depression symptom severity.
METHODS: In this cross-sectional study, individuals diagnosed with CRC 3.5 to 6 years ago completed questionnaires on sociodemographic information, medical comorbidities, anxiety symptoms (Beck Anxiety Inventory), and depressive symptoms (Inventory of Depressive Symptomatology). The general linear model analysis of covariance was used to identify factors associated with heightened anxiety or depressive symptom severity.
RESULTS: The sample included 91 CRC survivors, 40.7% women, mean age 69.1 years. A minority of CRC survivors had moderate (3.4%) or severe (2.3%) anxiety symptoms, and moderate (7.7%) or severe (0%) depressive symptoms. Shorter time since diagnosis and higher number of comorbid diseases were associated with higher anxiety symptom severity. Female sex and higher number of comorbid diseases were associated with higher depressive symptom severity.
CONCLUSION: From this explorative study, it follows that survivors with multiple comorbid diseases, shorter time since diagnosis, and female survivors might be at risk for higher anxiety and/or depressive symptom severity. Survivors with these characteristics might need extra monitoring.

Entities:  

Mesh:

Year:  2016        PMID: 26928565     DOI: 10.1097/MEG.0000000000000615

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

1.  An examination of depression, anxiety, and fear of recurrence among cancer survivors who participated in a virtual cognitive behavioral therapy (CBT)-based telephone coaching program.

Authors:  Patricia Nguyen; Ruth Heisey; Camille Quenneville; Elaine Goulbourne; Rumaisa Khan; Emma Rinaldo; Helen Chagigiorgis; Rebecca Shields; Carol Townsley
Journal:  Support Care Cancer       Date:  2022-05-24       Impact factor: 3.359

2.  Assessing Depressive Symptoms in Patients With Cancer Treated With Interleukin-2: A Comparison of 2 Measures.

Authors:  Shawn M McClintock; Robin B Dail; Laura S Howe-Martin; Tara K Mann; Donald E Bailey
Journal:  Cancer Nurs       Date:  2022-01-27       Impact factor: 2.760

3.  Suicidal Ideation in Newly-Diagnosed Chinese Cancer Patients.

Authors:  Yongfu Zhang; Wengao Li; Zijun Zhang; Hengwen Sun; Samradhvi Garg; Yuan Yang; Hongmei Wang
Journal:  Front Psychiatry       Date:  2020-07-23       Impact factor: 4.157

Review 4.  Anxiety and Depression in Cancer Survivors.

Authors:  Jean C Yi; Karen L Syrjala
Journal:  Med Clin North Am       Date:  2017-08-18       Impact factor: 5.456

5.  Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.

Authors:  Shirin ArdeshirRouhaniFard; Paul C Dinh; Patrick O Monahan; Sophie D Fossa; Robert Huddart; Chunkit Fung; Yiqing Song; Darren R Feldman; Robert J Hamilton; David J Vaughn; Neil E Martin; Christian Kollmannsberger; Lawrence Einhorn; Kurt Kroenke; Lois B Travis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-13       Impact factor: 4.254

6.  Gender Differences in Psychological Distress in Patients with Colorectal Cancer and Its Correlates in the Northeast of Iran.

Authors:  Nayyereh Aminisani; Hossein-Ali Nikbakht; Layla Shojaie; Esmat Jafari; Morteza Shamshirgaran
Journal:  J Gastrointest Cancer       Date:  2021-01-08

7.  Top 10 research priorities for early-stage colorectal cancer: a Canadian patient-oriented priority-setting partnership.

Authors:  Colleen Cuthbert; Nancy Nixon; Michael Vickers; Setareh Samimi; Krista Rawson; Ravi Ramjeesingh; Safiya Karim; Barry Stein; Garry Laxdal; Lorilee Dundas; Diane Huband; Emily Daze; Christie Farrer; Winson Y Cheung
Journal:  CMAJ Open       Date:  2022-03-29

8.  Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) study.

Authors:  Lynn Calman; Joshua Turner; Deborah Fenlon; Natalia V Permyakova; Sally Wheelwright; Mubarak Patel; Amy Din; Jane Winter; Alison Richardson; Peter W F Smith; Claire Foster
Journal:  Colorectal Dis       Date:  2021-11-25       Impact factor: 3.917

9.  Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors.

Authors:  L Leermakers; S Döking; B Thewes; A M J Braamse; M F M Gielissen; J H W de Wilt; E H Collette; J Dekker; J B Prins
Journal:  BMC Cancer       Date:  2018-07-18       Impact factor: 4.430

10.  Predicting anxiety in cancer survivors presenting to primary care - A machine learning approach accounting for physical comorbidity.

Authors:  Markus W Haun; Laura Simon; Halina Sklenarova; Verena Zimmermann-Schlegel; Hans-Christoph Friederich; Mechthild Hartmann
Journal:  Cancer Med       Date:  2021-06-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.